Cargando…

Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert

Yokukansan (YKS) and yokukansankachimpihange (YKSCH) are traditional Japanese Kampo medicines. The latter comprises YKS along with the medicinal herbs Citrus unshiu peel and Pinellia tuber. Both of these Kampo medicines are indicated for the treatment of night crying and irritability in children and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabuchi, Masahiro, Mizuno, Keita, Mizoguchi, Kazushige, Hattori, Tomohisa, Kase, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405124/
https://www.ncbi.nlm.nih.gov/pubmed/28491038
http://dx.doi.org/10.3389/fphar.2017.00235
_version_ 1783231708828532736
author Tabuchi, Masahiro
Mizuno, Keita
Mizoguchi, Kazushige
Hattori, Tomohisa
Kase, Yoshio
author_facet Tabuchi, Masahiro
Mizuno, Keita
Mizoguchi, Kazushige
Hattori, Tomohisa
Kase, Yoshio
author_sort Tabuchi, Masahiro
collection PubMed
description Yokukansan (YKS) and yokukansankachimpihange (YKSCH) are traditional Japanese Kampo medicines. The latter comprises YKS along with the medicinal herbs Citrus unshiu peel and Pinellia tuber. Both of these Kampo medicines are indicated for the treatment of night crying and irritability in children and for neurosis and insomnia in adults. In recent clinical trials, YKS exhibited ameliorative effects on the behavioral and psychological symptoms of dementia, such as aggressiveness, excitement, and irritability. In the present study, we aimed to clarify the involvement of cholinergic degeneration in the nucleus basalis of Meynert (NBM) in the development of aggressiveness in rats. Subsequently, using this animal model, the effects of YKS and YKSCH on aggressiveness were compared and the mechanisms underlying these effects were investigated. L-Glutamic acid (Glu) was injected into the right NBM of rats to induce deterioration of cholinergic neurons. On day 8 after Glu injection, aggressive behaviors were evaluated using resident–intruder tests. After the evaluation, YKS or YKSCH was administered to rats with aggressive behaviors daily for 7 days. In some groups, the 5-HT(1A) receptor antagonist WAY-100635 was coadministered with YKS or YKSCH over the same period. In other groups, locomotor activity was measured on days 12–14 after Glu injection. On day 15, immunohistochemistry was then performed to examine choline acetyltransferase (ChAT) activities in the NBM. Aggressive behaviors had developed on day 8 after Glu injection and were maintained until day 15. YKS and YKSCH significantly ameliorated the aggressive behaviors. These suppressive effects were entirely abolished following coadministration of WAY-100635. Finally, the number of ChAT-positive cells in the right NBM was significantly reduced on day 15 after Glu injection, and treatment with YKS or YKSCH did not ameliorate these reduced cell numbers. Our results show that unilateral Glu injections into the NBM of rats leads to the development of aggressive behaviors, which is thought to reflect cholinergic degeneration. YKS and YKSCH treatments ameliorated Glu-induced aggressive behaviors, and these effects were suggested to be mediated by 5-HT(1A) receptor stimulation, but not by improvement of cholinergic degeneration.
format Online
Article
Text
id pubmed-5405124
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54051242017-05-10 Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert Tabuchi, Masahiro Mizuno, Keita Mizoguchi, Kazushige Hattori, Tomohisa Kase, Yoshio Front Pharmacol Pharmacology Yokukansan (YKS) and yokukansankachimpihange (YKSCH) are traditional Japanese Kampo medicines. The latter comprises YKS along with the medicinal herbs Citrus unshiu peel and Pinellia tuber. Both of these Kampo medicines are indicated for the treatment of night crying and irritability in children and for neurosis and insomnia in adults. In recent clinical trials, YKS exhibited ameliorative effects on the behavioral and psychological symptoms of dementia, such as aggressiveness, excitement, and irritability. In the present study, we aimed to clarify the involvement of cholinergic degeneration in the nucleus basalis of Meynert (NBM) in the development of aggressiveness in rats. Subsequently, using this animal model, the effects of YKS and YKSCH on aggressiveness were compared and the mechanisms underlying these effects were investigated. L-Glutamic acid (Glu) was injected into the right NBM of rats to induce deterioration of cholinergic neurons. On day 8 after Glu injection, aggressive behaviors were evaluated using resident–intruder tests. After the evaluation, YKS or YKSCH was administered to rats with aggressive behaviors daily for 7 days. In some groups, the 5-HT(1A) receptor antagonist WAY-100635 was coadministered with YKS or YKSCH over the same period. In other groups, locomotor activity was measured on days 12–14 after Glu injection. On day 15, immunohistochemistry was then performed to examine choline acetyltransferase (ChAT) activities in the NBM. Aggressive behaviors had developed on day 8 after Glu injection and were maintained until day 15. YKS and YKSCH significantly ameliorated the aggressive behaviors. These suppressive effects were entirely abolished following coadministration of WAY-100635. Finally, the number of ChAT-positive cells in the right NBM was significantly reduced on day 15 after Glu injection, and treatment with YKS or YKSCH did not ameliorate these reduced cell numbers. Our results show that unilateral Glu injections into the NBM of rats leads to the development of aggressive behaviors, which is thought to reflect cholinergic degeneration. YKS and YKSCH treatments ameliorated Glu-induced aggressive behaviors, and these effects were suggested to be mediated by 5-HT(1A) receptor stimulation, but not by improvement of cholinergic degeneration. Frontiers Media S.A. 2017-04-26 /pmc/articles/PMC5405124/ /pubmed/28491038 http://dx.doi.org/10.3389/fphar.2017.00235 Text en Copyright © 2017 Tabuchi, Mizuno, Mizoguchi, Hattori and Kase. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tabuchi, Masahiro
Mizuno, Keita
Mizoguchi, Kazushige
Hattori, Tomohisa
Kase, Yoshio
Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
title Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
title_full Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
title_fullStr Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
title_full_unstemmed Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
title_short Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert
title_sort yokukansan and yokukansankachimpihange ameliorate aggressive behaviors in rats with cholinergic degeneration in the nucleus basalis of meynert
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405124/
https://www.ncbi.nlm.nih.gov/pubmed/28491038
http://dx.doi.org/10.3389/fphar.2017.00235
work_keys_str_mv AT tabuchimasahiro yokukansanandyokukansankachimpihangeameliorateaggressivebehaviorsinratswithcholinergicdegenerationinthenucleusbasalisofmeynert
AT mizunokeita yokukansanandyokukansankachimpihangeameliorateaggressivebehaviorsinratswithcholinergicdegenerationinthenucleusbasalisofmeynert
AT mizoguchikazushige yokukansanandyokukansankachimpihangeameliorateaggressivebehaviorsinratswithcholinergicdegenerationinthenucleusbasalisofmeynert
AT hattoritomohisa yokukansanandyokukansankachimpihangeameliorateaggressivebehaviorsinratswithcholinergicdegenerationinthenucleusbasalisofmeynert
AT kaseyoshio yokukansanandyokukansankachimpihangeameliorateaggressivebehaviorsinratswithcholinergicdegenerationinthenucleusbasalisofmeynert